Skip to main content
Gynecologic Oncology Reports logoLink to Gynecologic Oncology Reports
. 2016 Apr 26;17:16–19. doi: 10.1016/j.gore.2016.04.004

Solitary fibrous tumor of the greater omentum mimicking an ovarian tumor in a young woman

Elisabet Rodriguez Tarrega 1,, Juan Jose Hidalgo Mora 1, Vicente Paya Amate 1, Olivia Vega Oomen 1
PMCID: PMC4899079  PMID: 27354994

Abstract

We report a case of solitary fibrous tumor (SFT) of greater omentum in a young woman. SFT arising from the greater omentum can mimic a gynecologic neoplasm. SFTs are generally benign but some of them are malignant and have uncertain prognosis. An adequate follow-up is essential in these patients.

Keywords: Solitary fibrous tumor, Hemangiopericytoma, Greater omentum, Laparoscopic surgery, Mesenchymal tumor, Vascular tumor

1. Introduction

A solitary fibrous tumor (SFT) is a rare mesenchymal tumor previously called hemangiopericytoma (Fletcher, 2014). It has been commonly considered as intrathoracic tumor, although there have been many reported cases of extrathoracic SFT, such as those in skin, muscles, thyroid, retroperitoneum, liver and so on (Van Houdt et al., 2013). SFT originating from greater omentum is extremely rare and only few cases in this location have been described.

We report a case of SFT of the greater omentum in a young woman, which mimicked a gynecologic neoplasm. We have also summarized the clinical data of the reported cases of SFT arising from greater omentum (Table 1).

Table 1.

Solitary fibrous tumors originating from the greater omentum: summary of reported cases.

Reference Age (years) Gender Symptoms Treatment Tumor size (cm) Mitotic figures Recurrence Outcome (months)
1 Stout et al (Kaneko et al., 2003) 92 M Abdominal mass None 12 × 9 Absent DOO
2 Stout et al (Kaneko et al., 2003) 63 M Abdominal mass with pain Excision 14 × 13 Absent None NED (13 months)
3 Stout et al (Kaneko et al., 2003) 57 F NA Excision NA (3090 g) 2/50HPF NA NA
4 Stout et al (Kaneko et al., 2003) 64 M Abdominal pain, nausea Excision 28 × 20 11/50HPF Yes, peritoneum, liver and lung DOD (24 months)
5 Goldberger et al (Kaneko et al., 2003) 30 F Abdominal pain Excision 8 × 8 NA None NED (16 months)
6 Imachi et al (Kaneko et al., 2003) 62 F Abdominal distensión with pain Excision, omentectomy and chemotherapy 24 × 20 12/10HPF Peritoneum AWD (11 months)
7 Schwartz et al (Kaneko et al., 2003) 40 M Abdominal mass with pain and weight loss Excision (laparotomy), omentectomy and chemotherapy 20 × 13.5 20/10HPF Peritoneum DOD (20 months)
8 Cajano et al (Kaneko et al., 2003) 49 F Abdominal pain Excision, omentectomy and chemotherapy 10 × 10 NA Peritoneum and liver DOD (24 months)
9 Bertolotto et al (Bertolotto et al., 1996) 33 F Abdominal pain Excision 6 × 5 Absent None NED (24 months)
10 Rao et al (Kaneko et al., 2003) 67 F Abdominal mass Excision and omentectomy 17 × 12 Sparse None NED (22 months)
11 Kaneko et al (Kaneko et al., 2003) 70 F Abdominal mass Excision 10 × 8 Absent None NED (12 months)
12 Bovino et al (Bovino et al., (2003) 46 F Abdominal pain, nausea and vomiting Excision, omentectomy, appendectomy and double adnexectomy 7 × 4 < 10/HPF None NED (6 months)
13 Ahmad et al (Ahmad et al. (2004) 74 F Abdominopelvic mass Excision NA Many Yes, paraaortic lymph nodes, liver DOD (4 months)
14 Patriti et al (Zong et al. (2012) 24 M Abdominal pain, diarrhea, fever and hemoperitoneum Excision and omentectomy (laparoscopic) 3.2 × 2.5 3/HPF None NED (24 months)
15 Shiba et al (Shiba et al. (2007) 41 F Abdominal pain Excision 5.5 × 4.5 × 4 Absent None NED (6 months)
16 Slupski et al (Slupski et al. (2007) 43 M NA Excision NA NA Yes, local, retroperitoneum and liver NED 18 years, NED (3 months)a
17 Küçük et al (Küçük et al., 2009) 70 M Abdominal pain, nausea and vomiting Urgent excision (laparotomy) by intraabdominal bleeding 12 × 10 × 6 Absent None NA
18 Zong et al (Zong et al., 2012) 29 M Abdominal mass and weight loss Excision (laparotomy) 28 × 25 × 11 < 4/10HPF None NED (48 months)
19 Harada et al (Harada et al., 2014) 62 F Abdominal mass and endometrial adenocarcinoma Excision (laparotomy), omentectomy, lymphadenectomy, hysterectomy, double adnexectomy and chemotherapyb 10 > 10/10HPF None NED (48 months)
20 Sato et al (Sato et al., 2014) 85 F Abdominal mass and portal venous dilatation Excision and omentectomy (laparotomy) 19 × 17 × 13 2/10HPF None NED (28 months)
21 Urabe et al (Urabe et al., 2015) 52 M Asymptomatic casual finding Excision (laparoscopy + laparotomy) 1.6 NA None NED (11 months)
22 Present case 34 F Asymptomatic abdominal mass Excision and omentectomy (laparoscopy) 6 × 5 13/10HPF None NED (32 months)

NA: not available, HPF: high-power fields, DOO: died of other causes, NED: no evidence of disease, DOD: died of disease, AWD: alive with disease.

a

Patient with NED for 18 years, then local recurrence and metastases were diagnosed, second surgery was performed and later patient with NED for 3 months.

b

For the uterine cancer.

2. Case report

A 34-year-old woman with unremarkable medical history was diagnosed of pelvic mass in a routine gynecological exam. On physical examination, a hard, mobile and nontender mass was palpated in retrouterine location. Ultrasound revealed a pelvic mass of 6 cm with echogenicity similar to myometrium (Fig. 1). A solid ovarian lesion (risk of malignancy of 34% with logistic regression model LR2) vs. subserous uterine myoma was suspected by sonographic findings. Tumor marker levels (CA-125, CA 19-9, CEA) were within the normal range.

Fig. 1.

Fig. 1

Ultrasound images showing a pelvic mass measuring 60 × 40 mm.

With this differential diagnosis a laparoscopy was performed which showed a well-circumscribed, pedunculated, vascular tumor appended to the great omentum (Fig. 2). The feeding artery to the tumor was gastroepiploic artery and two lymph nodes with diameter greater than 1 cm were observed in the omentum. Laparoscopic resection of the tumor and great omentum was performed and then, both of them were removed by open mini-laparotomy (Fig. 3).

Fig. 2.

Fig. 2

Laparoscopic findings. a) A well-circumscribed, pedunculated, vascular tumor (arrow) arising from the great omentum (asterisk). b) Detail of vascular pedicle (arrow).

Fig. 3.

Fig. 3

Image showing surgical specimen: tumor and great omentum.

Histological examination showed characteristic features of benign solitary fibrous tumor in some areas of the tumor, such as a patternless architecture varying cellularity variably prominent hyaline stromal collagen and branched blood vessels. However elsewhere, the tumor was much more hypercellular and consisted of rounded or ovoid cells with limited amounts of amphophilic cytoplasm showing frequent mitotic figures numbering up 13 per 10 high-power fields (HPF). Immunohistochemical staining revealed diffuse positivity for CD34, multifocal positivity for CD99 and nuclear positivity for beta catenin, while smooth muscle actin (SMA), desmin, kit and DOG-1 were negative. According to these findings, the final diagnosis was malignant SFT.

The patient experienced no postoperative complications. The case was reviewed by a multidisciplinary oncology team and she was advised not to undergo adjuvant treatment, but a careful follow up was initiated to rule out local recurrence or distant metastasis. At 32 months after surgery, the patient is disease-free.

3. Discussion

The prevalence of SFT is low and those originating from greater omentum are extremely rare.

Patients diagnosed of this type of tumor can experience abdominal pain or vomiting due to an abdominal mass, but they are mostly asymptomatic, as in the current case. An acute abdomen because of the rupture of the tumor has been described in some patients (Bovino et al., 2003, Küçük et al., 2009).

According to the reported cases, SFT of the greater omentum usually occurs in the fifth to seventh decade of life, with no gender predilection. Nevertheless, our patient was younger than most of the other patients affected by this tumor.

Diagnosing SFT is difficult because of the resemblance to other lesions such as leiomyoma or mesothelioma (Van Houdt et al., 2013). Moreover, if SFT originates from greater omentum and is pedunculated as our case, it can mimic other more common pelvic tumors.

Immunohistochemical staining is useful to establish the diagnosis. SFTs are generally positive for CD34, CD99 and bcl-2 and occasionally SMA, but they are usually negative for S-100, desmin and cytokeratins (Fletcher, 2014, Van Houdt et al., 2013).

Ultrasonographic appearance of SFT has been described as a highly vascularized solid mass with well-defined margins; computerized tomography usually shows similar findings (Bertolotto et al., 1996). However, imaging studies are not specific and preoperative diagnosis becomes almost impossible.

SFTs are generally benign. Nevertheless, approximately 15–20% of them are malignant; especially tumors larger than 10 cm. Histological criteria of malignancy include high cellularity and mitotic activity (more than 4 per 10 HPF), pleomorphism, cytonuclear atypia and tumor hemorrhage or necrosis (Demicco et al., 2012).

Surgical resection is the treatment of choice, but malignant SFT has a potential for local recurrence and metastases, even several years after surgery (Slupski et al., 2007). In some of the reported cases, an omentectomy was carried out in addition to tumor excision, even though there is no evidence that it decreases local recurrence. We decided to resect the great omentum due to the finding of two suspicious lymph nodes.

At present, based upon the low incidence of SFT and poor existing data, the prognosis of these patients remains uncertain. Few studies have reviewed the prognostic markers of SFTs regardless of their location. Demicco et al. (2012) carried out a retrospective study involving 110 patients and they found 5- and 10-year disease-specific survival rates of 89 and 73%, respectively. Moreover, they did a risk of metastasis stratification model based on age, size and mitotic index, which classified patients into low, moderate or high risk groups. According to this model, our patient would be into a moderate risk group. Later, Van Houdt et al. (2013) analyzed the outcomes after diagnosis and treatment of SFT in 81 patients, local recurrence rate at 5 years was 29% and metastasis rate was 34%. Factors related to worse prognosis were tumor size (> 10 cm), positive resection margins and high mitosis rate (more than 4 per 10HPF).

Of the 21 cases of SFT of the greater omentum reported, only 9 had a tumor size ≤ 10 cm, as our patient, and it is considered a good prognostic factor. On the other hand, high mitosis rate seems to be related to local recurrence and metastases, although data are not conclusive due to the limited number of cases.

The current case was considered as malignant because of the histological findings and complete excisional laparoscopic surgery was performed, with tumor-free surgical margins. Because of its size of 6 cm, it could be expected as a good outcome, but the high mitosis rate increases the risk of recurrence and metastases.

Nowadays, there is no evidence for a beneficial role of adjuvant treatment, but some reports proposed adjuvant radiotherapy and show response to chemotherapy and other biological treatments, although its effectiveness has not been proven (Park et al., 2011, Van Houdt et al., 2013). Therefore, we decided not to provide adjuvant treatment to our patient. However, as the clinical behavior of solitary fibrous tumors is difficult to predict and she had a significant risk of recurrence or metastasis, a long-term follow up was initiated.

Fortunately, she is disease-free 32 months after surgery.

4. Conclusions

In summary, we have presented a rare case of SFT arising from greater omentum in a young woman, which mimicked a gynecologic tumor. This case is novel because the age of the patient is lower than the expected in this type of tumor; besides, the combination of prognostic factors is not the most common: on the one hand, tumor size is a good prognostic factor, but otherwise the high mitotic index is associated with poor prognosis.

We want to emphasize that the diagnosis of a malignant tumor in a woman of reproductive age has some implications since tumor treatment and follow-up can affect her fertility. The gynecologist should consider alternative diagnoses when faced with a pelvic tumor and have support of other specialists to ensure the best treatment for each patient. In cases of uncertain prognosis like this, an adequate follow-up is essential.

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-chief of this journal on request.

Contributor Information

Elisabet Rodriguez Tarrega, Email: e.rodriguez.tarrega@gmail.com.

Juan Jose Hidalgo Mora, Email: hidalmo@yahoo.es.

Vicente Paya Amate, Email: vpayaa@sego.es.

Olivia Vega Oomen, Email: oliviaoomen@hotmail.com.

References

  1. Ahmad G.F., Athavale R., Hamid B.N.A., Davies-Humphreys J. Pelvic malignant hemangiopericytoma mimicking an ovarian neoplasm; a case report. J. Reprod. Med. 2004;49:404–407. [PubMed] [Google Scholar]
  2. Bertolotto M., Cittadini G., Crespi G., Perrone C., Pastorino R. Hemangiopericytoma of the greater omentum: US and CT appearance. Eur. Radiol. 1996;6:454–456. doi: 10.1007/BF00182467. [DOI] [PubMed] [Google Scholar]
  3. Bovino A., Basso L., Di Giacomo G., Codacci Pisanelli M., Basile U., De Toma G. Haemangiopericytoma of greater omentum. A rare cause of acute abdominal pain. J. Exp. Clin. Cancer Res. 2003;22:649–650. [PubMed] [Google Scholar]
  4. Demicco E.G., Park M.S., Araujo D.M., Fox P.S., Bassett R.L., Pollock R.E., Lazar A.J., Wang W.-L. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod. Pathol. 2012;25:1298–1306. doi: 10.1038/modpathol.2012.83. [DOI] [PubMed] [Google Scholar]
  5. Fletcher C.D.M. The evolving classification of soft tissue tumours — an update based on the new 2013 WHO classification. Histopathology. 2014;64:2–11. doi: 10.1111/his.12267. [DOI] [PubMed] [Google Scholar]
  6. Harada N., Nobuhara I., Haruta N., Higashiura Y., Watanabe H., Ohno S. Concurrent malignant solitary fibrous tumor arising from the omentum and grade 3 endometrial endometrioid adenocarcinoma of the uterus with p53 immunoreactivity. Case Rep. Obstet. Gynecol. 2014;2014:1–4. doi: 10.1155/2014/216340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaneko K., Shirai Y., Wakai T., Hasegawa G., Kaneko I., Hatakeyama K. Hemangiopericytoma arising in the greater omentum: report of a case. Surg. Today. 2003;33:722–724. doi: 10.1007/s00595-003-2559-6. [DOI] [PubMed] [Google Scholar]
  8. Küçük H.F., Gülmez S., Kaptanoğlu L., Akyol H., Kurt N., Yavuzer D. Acute abdomen due to rupture of hemangiopericytoma of the greater omentum: case report. Ulus. Travma Acil Cerrahi Derg. 2009;15:611–613. [PubMed] [Google Scholar]
  9. Park M.S., Patel S.R., Ludwig J.A., Trent J.C., Conrad C.A., Lazar A.J., Wang W.-L., Boonsirikamchai P., Choi H., Wang X., Benjamin R.S., Araujo D.M. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011;117:4939–4947. doi: 10.1002/cncr.26098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sato T., Yamaguchi S., Koyama I., Okada Y., Kato Y. Acute life-threatening portal venous dilatation induced by a huge solitary fibrous tumor of the omentum. Hepato-Gastroenterology. 2014;61:2200–2202. [PubMed] [Google Scholar]
  11. Shiba H., Misawa T., Kobayashi S., Yokota T., Son K., Yanaga K. Hemangiopericytoma of the greater omentum. J. Gastrointest. Surg. 2007;11:549–551. doi: 10.1007/s11605-007-0099-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Slupski M., Piotrowiak I., Wlodarczyk Z. Local recurrence and distant metastases 18 years after resection of the greater omentum hemangiopericytoma. World J. Surg. Oncol. 2007;5:63. doi: 10.1186/1477-7819-5-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Urabe M., Yamagata Y., Aikou S., Mori K., Yamashita H., Nomura S., Shibahara J., Fukayama M., Seto Y. Solitary fibrous tumor of the greater omentum, mimicking gastrointestinal stromal tumor of the small intestine: a case report. Int. Surg. 2015;100:836–840. doi: 10.9738/INTSURG-D-14-00141.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Van Houdt W.J., Westerveld C.M.A., Vrijenhoek J.E.P., van Gorp J., van Coevorden F., Verhoef C., van Dalen T. Prognosis of solitary fibrous tumors: a multicenter study. Ann. Surg. Oncol. 2013;20:4090–4095. doi: 10.1245/s10434-013-3242-9. [DOI] [PubMed] [Google Scholar]
  15. Zong L., Chen P., Wang G.-Y., Zhu Q.-S. Giant solitary fibrous tumor arising from greater omentum. World J. Gastroenterol. 2012;18:6515–6520. doi: 10.3748/wjg.v18.i44.6515. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gynecologic Oncology Reports are provided here courtesy of Elsevier

RESOURCES